1
|
Asif M, Almehmadi M, Alsaiari AA, Allahyani M. Diverse Pharmacological Potential of different Substituted Pyrazole Derivatives. Curr Org Synth 2024; 21:858-888. [PMID: 37861007 DOI: 10.2174/0115701794260444230925095804] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2023] [Revised: 08/01/2023] [Accepted: 08/25/2023] [Indexed: 10/21/2023]
Abstract
The chemistry of heterocyclic compounds has been a topic of research interest. Some five-membered heterocyclic compounds have been the subject of extensive research due to their different types of pharmacological effects. The five-membered nitrogen-containing heterocyclic compounds pyrazole, pyrazoline, and pyrazolone derivatives have a lot of interest in the fields of medical and agricultural chemistry due to their diverse spectrum of therapeutic activities. Various substituted pyrazole, pyrazoline, and pyrazolone compounds exhibited diverse pharmacological effects like Anti-microbial, anti-inflammatory, anti-tubercular, anti-fungal, anti-malarial, anti-diabetic, diuretic, anti-depressant, anticonvulsant, antioxidant, anti-leishmanial, antidiabetic, and antiviral, etc. In recent decades, the synthesis of numerous pyrazole, pyrazoline, and pyrazolone derivatives by different synthetic methods as well as research into their chemical and biological behavior have become more important. This review focuses on synthetic methods of the pyrazole, pyrazoline, and pyrazolone derivatives, which have significant biological properties and a variety of applications.
Collapse
Affiliation(s)
- Mohammad Asif
- Department of Pharmaceutical Chemistry, Era College of Pharmacy, Era University, Lucknow, 226003, Uttar Pradesh, India
| | - Mazen Almehmadi
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif, 21944, Saudi Arabia
| | - Ahad Amer Alsaiari
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif, 21944, Saudi Arabia
| | - Mamdouh Allahyani
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif, 21944, Saudi Arabia
| |
Collapse
|
2
|
Radioiodination and in vivo assessment of the potential of newly synthesized pyrrolizine-5-carboxamides derivative in tumor model. Appl Radiat Isot 2020; 166:109369. [PMID: 32828009 DOI: 10.1016/j.apradiso.2020.109369] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2020] [Revised: 07/24/2020] [Accepted: 08/04/2020] [Indexed: 01/03/2023]
Abstract
Recently, pyrrolizine derivatives have been reported to possess numerous anticancer activities. In a previous study, (EZ)-6-((4-chlorobenzylidene)-amino)-7-cyano-N-(p-tolyl)-2,3-dihydro-1H-pyrrolizine carboxamide (EZPCA) compound was synthesized and the cytotoxic activity of EZPCA toward COX-2 enzyme (overexpressed in cancer cells) was reported. In order to assess the suitability of this compound as a promising pilot structure for in vivo applications, EZPCA was radiolabeled with radioiodine-131 (131I) and various factors affecting radiolabeling process were studied. Quality control studies of [131I]iodo-EZPCA were performed using paper chromatography and HPLC was used as a co-chromatographic technique for confirming the radiochemical yield. Biodistribution studies of [131I]iodo-EZPCA were undertaken in normal and tumor bearing mice. The radiochemical yield percentage of [131I]iodo-EZPCA was 94.20 ± 0.12%. The biodistribution results showed evident tumor uptake of [131I]iodo-EZPCA with promising target/non-target (T/NT) ratios. As a conclusion, these data suggest that [131I]iodo-EZPCA had high binding efficiency, high tumor uptake and sufficient stability to be used be used in diagnostic studies.
Collapse
|
3
|
Ismail MMF, Abdulwahab HG, Elnagdi MH. Design, synthesis, and in vitroanticancer screening of novel pyrazolinyl‐pyrazole/1, 2, 3‐triazole hybrids. J Heterocycl Chem 2020. [DOI: 10.1002/jhet.4076] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Affiliation(s)
- Magda M. F. Ismail
- Pharmaceutical Chemistry Department, Faculty of Pharmacy (Girls) Al‐Azhar University Cairo Egypt
| | - Hanan G. Abdulwahab
- Pharmaceutical Chemistry Department, Faculty of Pharmacy (Girls) Al‐Azhar University Cairo Egypt
| | - Mohamed H. Elnagdi
- Department of Chemistry, Faculty of Science University of Kuwait Safat Kuwait
| |
Collapse
|
4
|
Fayed AA, Bahashwan SA, Yousif MNM, Shafey HME, Amr AE, Yousif NM, Shadid KA. Synthesis and Antiproliferative Activity of Some Newly Synthesized Pyrazolopyridine Derivatives. RUSS J GEN CHEM+ 2019. [DOI: 10.1134/s1070363219060173] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
5
|
Ranganathan R, Archana S, Dinesh M, Jaabil G, Nagarajan S, Ponnuswamy A, Saranya K, Murugavel S. A Smart and Efficient One-Pot Green Synthesis of Novel 1, 2, 3-Triazolyl Pyrazoline-/Indazolyl-Carbothioamide Hybrids under Solvent-Free Grinding Strategy at Room Temperature. ChemistrySelect 2018. [DOI: 10.1002/slct.201802346] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Affiliation(s)
- Raja Ranganathan
- Department of Organic Chemistry; School of Chemistry; Madurai Kamaraj University; Madurai 625021 India
- Department of Chemistry; Mahendra Institute of Engineering & Technology; Namakkal 637 503 Tamilnadu India
| | - Sivasubramaniyan Archana
- Department of Organic Chemistry; School of Chemistry; Madurai Kamaraj University; Madurai 625021 India
| | - Murugan Dinesh
- Department of Organic Chemistry; School of Chemistry; Madurai Kamaraj University; Madurai 625021 India
| | - George Jaabil
- Department of Organic Chemistry; School of Chemistry; Madurai Kamaraj University; Madurai 625021 India
| | - Sangaraiah Nagarajan
- Department of Organic Chemistry; School of Chemistry; Madurai Kamaraj University; Madurai 625021 India
- Key Laboratory for Radiation Physics and Technology of Ministry of Education; Institute of Nuclear Science and Technology; Sichuan University; Chengdu China
| | - Alagusundaram Ponnuswamy
- Department of Organic Chemistry; School of Chemistry; Madurai Kamaraj University; Madurai 625021 India
| | - Kanagarajan Saranya
- Department of Physics; Thanthai Periyar Government Institute of Technology; Vellore 608 002, Tamilnadu India
| | - Saminathan Murugavel
- Department of Physics; Thanthai Periyar Government Institute of Technology; Vellore 608 002, Tamilnadu India
| |
Collapse
|
6
|
Accessing anti-human lung tumor cell line (A549) potential of newer 3,5-disubstituted pyrazoline analogs. ARAB J CHEM 2017. [DOI: 10.1016/j.arabjc.2014.11.002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
7
|
Abstract
Nitrogen heterocyclic compounds such as pyrazolines have been found to possess a broad spectrum of biological activities such as anticancer, antitubercular, anti-inflammatory, analgesic, and antidepressant activities. Pyrazoline derivatives IV, V (a–e) have been synthesized from the intermediate chalcones III (a–h) by cyclizing with phenyl hydrazine and hydrazine hydrate. The structures of these compounds were confirmed by IR, NMR, and mass spectroscopy. Biological studies of the synthesized compounds showed promising antitumor, analgesic, and anti-inflammatory activities. The compounds were tested for their in vitro antitumor activity against EAC tumor cell lines. Compounds IVa and IVb showed the highest cytotoxicity of 80% at a 200 μg mL concentration. Among the tested compounds, IVa and Vd seem to be more effective analgesic agents. Compounds IVc, IVd, and Ve are found to be the most effective anti-inflammatory agents. Thus the results show that synthesized compounds possess antitumor, analgesic, and anti-inflammatory activity. It was observed that the test compounds with electron withdrawing groups (halogens) on the aromatic ring favors antitumor, analgesic, and anti-inflammatory activity.
Collapse
Affiliation(s)
- Pj Jainey
- Department of Pharmaceutical Chemistry, NGSM Institute of Pharmaceutical Sciences of Nitte University, Deralakatte, Mangalore, Karnataka, India
| | | |
Collapse
|
8
|
Ali MA, Ismail R, Choon TS, Pandian S, Hassan Ansari MZ. Antimycobacterial activity: synthesis of novel 3-(substituted phenyl)-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]isoxazole analogues. J Enzyme Inhib Med Chem 2011; 26:598-602. [PMID: 21714764 DOI: 10.3109/14756366.2010.529805] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
In this study, a series of novel 3-(substituted phenyl)-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]isoxazole analogues were synthesized and evaluated for antimycobacterial activity against Mycobacterium tuberculosis (MTB) H(37)Rv and isoniazid resistant M. tuberculosis (INHR-MTB). All the newly synthesized compounds were showing moderate to high inhibitory activities. The compound 6,7-dimethoxy-3-(4-chloro phenyl)-4H-indeno[1,2-c]isoxazole (4b) was found to be the most promising compound, active against MTB H(37)Rv and INHR-MTB with minimum inhibitory concentrations of 0.22 and 0.34 μM.
Collapse
Affiliation(s)
- Mohamed Ashraf Ali
- Pharmacogenetic and Novel Therapeutic, Institute for Research in Molecular Medicine, Universiti of Sains Malysia, Pennag-11800, Malaysia.
| | | | | | | | | |
Collapse
|
9
|
Shahar Yar M, Bakht MA, Siddiqui AA, Abdullah MM, De Clercq E. Synthesis and evaluation of in vitro antiviral activity of novel phenoxy acetic acid derivatives. J Enzyme Inhib Med Chem 2009; 24:876-82. [DOI: 10.1080/14756360802447917] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
Affiliation(s)
- M. Shahar Yar
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hamdard University, New Delhi, 110062, India
| | - M. Afroz Bakht
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hamdard University, New Delhi, 110062, India
| | - A. A. Siddiqui
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hamdard University, New Delhi, 110062, India
| | - M. M. Abdullah
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hamdard University, New Delhi, 110062, India
| | - Erik De Clercq
- Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000, Leuven, Belgium
| |
Collapse
|
10
|
Shahar Yar M, Mustaqeem Abdullah M, Husain A, Bhakht MA, De Clercq E. Synthesis and evaluation of in vitro antiviral activity of 2-[3-(substituted phenyl)-4,5-dihydro-1H-5-pyrazolyl]benzofuran-3-yl chloride derivatives. J Enzyme Inhib Med Chem 2009; 24:949-56. [DOI: 10.1080/14756360802560677] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
Affiliation(s)
- M. Shahar Yar
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hamdard University, New Delhi-110062, India
| | - M. Mustaqeem Abdullah
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hamdard University, New Delhi-110062, India
| | - A. Husain
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hamdard University, New Delhi-110062, India
| | - M. Afroz Bhakht
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hamdard University, New Delhi-110062, India
| | - Erik De Clercq
- Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium
| |
Collapse
|